Global Brain Monitoring Devices Market Information, by Application (Stroke, Headache Disorders, Epilepsy, Parkinson’s Disease), By Type (X Rays, MRI Systems, CT), By End Users (Hospital & Clinical, Research Laboratories, and Academic Institutes), by Region - Forecast to 2025

Market Forecast

Global Brain Monitoring Devices Market is expected to grow at a CAGR of 6% during the forecast period 2019 to 2025.

Market Synopsis

The ability to quantify reliable alterations in the physical and biochemical environment after a brain injury is of great value in the prevention, medication, and understanding of secondary injuries.

Moreover, according to CDC, traumatic brain injury is a leading cause of \mortality, responsible for 2.8 million accidents and emergency department visits annually in the US and about 1 million in the UK. It is one of the most common causes of mortality in people aged under 25, and its incidence is high in adults and infants as well.

Market Influencer

Intracranial pressure (ICP) monitoring, as stand-alone value or study of a dynamic trend, has become an important diagnostic tool in the diagnosis and management of multiple neurological conditions. Efforts have been made to measure ICP non-invasively, but this process is not a clinical reality yet. There is differing evidence that monitoring of ICP is associated with a better outcome, and further RCTs based on management protocol are warranted.

Market Drivers

• Increase the prevalence of epilepsy amongst the geriatric population
  
  
  
  • Epilepsy is a chronic disorder caused by neurological complications. Although it could affect anybody irrespective of age and gender, in the geriatric population, its prevalence is significant and continuously increasing. As per the 2018 study published in the Neuroepidemiology Journal, the prevalence ratio of active epilepsy in the general population was 6.4 per 1,000 individuals. Whereas, in individuals aged 60 years or older, the prevalence ratio was 7.17 per 1,000 individuals.
  
  
  
  

Moreover, as per the statistics of WHO in 2017, around 50 million people all over the world were affected with epilepsy. Furthermore, as stated by the Epilepsy Society, epilepsy is commonly diagnosed in people over 65, and 5.2% of 50 million are people aged above 60

• Increasing cases of brain injuries due to road accidents 
  
  
  
  • Severe brain injuries and trauma can trigger post-traumatic epilepsy (PTE) and post-traumatic seizures (PTS). According to the Brain Injury Association of Michigan, among the 40% of cases of epilepsy, brain injury is one of the most frequent causes. In most of the cases, road accidents lead to the brain and head-related injuries in the youth population. The number of road accidents is increasing in developed countries and causing serious injuries to the victims. These include head and brain injuries that are responsible for developing epilepsy. According to the Headway (the brain injury association), in 2017, more than 348,453 cases of acquired brain injury were registered in the UK and is continuously increasing from 2005-06 with the rate of 10%. The increasing number of brain injuries are responsible for driving the growth of the market during the forecast period.
  
  
  
  

• Growing cases of headache disorders

• Increasing awareness about stroke treatment

Market Restraints

• High costs associated with the treatment and monitoring. For example, Medtronic’s LOC brain monitor range costs from about USD 4,000 to more than USD 5,500, which eventually increases monitoring costs.

Segmentation

By Application

• Stroke: High incidence of stroke is expected to support the growth of this segment during the forecast period. For instance, in the US, according to the American Heart Association, about 795,000 individuals suffer from strokes annually. Also, in the Americas, around 4 million stroke patients survived with impairments, and about 15% to 30% are living with a permanent disability. Moreover, according to the American Heart Association, around USD 33 billion is being spent as a direct and indirect cost for stroke in the US. Hence, the stroke segment is holding the largest market share in the global brain monitoring devices market.

• Headache Disorders: Headache disorders are among the most common disorders of the nervous system. According to WHO, it has been anticipated that almost half of the adult population has had a headache at least once within the last year. Further, headache has been underestimated, under-recognized and under-treated throughout the world, which is further anticipated to contribute to the market growth.

• Epilepsy: According to the World Health Organization (WHO) Report 2017, approximately 50 million people worldwide had epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of the people with epilepsy live in low- and middle-income countries. In many parts of the world, people with epilepsy and their families suffer from stigma and discrimination. According to the new morbidity and mortality weekly report 2017, more people were living with epilepsy in the US than ever before. As a result, the epilepsy segment is expected to be the fastest-growing segment in the brain monitoring device market.

• Parkinson’s Disease: Parkinson's disease is a liberal nervous system disorder that affects body movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Tremors are common, but the disorder also commonly causes stiffness or slowing of movement.

By Type

• X Rays: X-rays systems are highly preferred during medical diagnosis as they are comparatively affordable than similar medical procedures such as MRI or CT scans. The rising number of product clearances in recent years is significantly contributing to the growth of this segment. For instance, in February 2019, Koninklijke Philips N.V. received 510(k) clearance from the US Food and Drug Administration (FDA) to market the DigitalDiagnost C90, its newest premium digital radiography system. Thus, this segment is expected to showcase high growth potential over the near future. The X Rays segment is expected to hold the largest market share in the global brain monitoring devices market.

• MRI Systems: MRI is a non-invasive medical imaging technique performed in radiology that uses strong magnetic fields and radio waves to produce detailed images of the inside of the body. The MRI segment would register a substantial CAGR during the forecast period owing to its growing adoption by healthcare providers as MRI provides a clearer and more detailed pictures. However, MRI is costlier than X-ray imaging, which is anticipated to affect its adoption during the next six years. MRI systems available in the market are Ingenia Edition 3.0T, Ingenia Ambition 1.5T, and Ingenia MR-RT (Philips Healthcare) and MAGNETOM Sola.

• CT: Computed tomography is the imaging process which uses ultra-advanced ray technology to produce a more detailed and cross-sectional image of the human body. As per an article published by CBS News, the number of CT scans performed each year in the US was 3 million in 1980, which increased to 80 million in 2015. Rising adoption of CT scans is expected to boost the market growth over the forecast period

By End-User

• Hospital & Clinical: Hospitals and clinics have a large control of the global market for brain monitoring devices. The positive growth of hospitals and clinics segment is attributed to factors such as growing prevalence and incidence of the brain disorders

• Research Laboratories and Academic Institutes: Research Laboratories and Academic Institutes take up the second-largest share due to the rising research and development in the market

By Region

• Americas: The global brain monitoring devices market in the Americas is segmented into North America and Latin America. In this region, North America is expected to dominate the market. The market growth in this region is mainly due to the increasing prevalence of epilepsy disorders among the geriatric population. According to the Center for Disease Control and Prevention (CDC) report, 2015, 1.2% of the US population was suffering from epilepsy that is 3.4 million people. Out of this, 3 million adult population and 470,000 children had epilepsy.

• Further, according, to the Epilepsy Foundation of America Organization, in 2018, 1.3 to 2.8 million people were diagnosed with epilepsy disease in the US. Moreover, as stated by the World Health Organization report 2016, the prevalence rate of epilepsy in Brazil was 7.8/1000 inhabitants, and the overall prevalence rate of active epilepsy was 5.6/1000 inhabitants. This finding suggested that there will be increased demand for brain monitoring devices for treatment and diagnosis in the present and near future.

• Asia-Pacific: Asia-Pacific is expected to exhibit the fastest market growth from 2019 to 2025 owing to the growing older population and the high number of neurological diseases. According to a research study, around 1.7 million people have Parkinson's in China. Similarly, in 2018, around 30,000 people have multiple sclerosis in China. The increasing geriatric population is likely to support the growth of this region in the market. In India, according to the report published by the United Nations Population Fund (UNFPA), the share of the population over the age of 60 was 8% in 2015 and is expected to reach 19% by 2050. Moreover, in 2016, according to the research study, more than 420,000 people suffer from a stroke in Australia. The high numbers of people who suffer from neurological disease will support the growth of the market.

Key Players

• Advanced Brain Monitoring


• Philips Healthcare


• GE Healthcare


• Siemens Healthineers


• Nihon Kohden Corporation


• Medtronic


• Drägerwerk AG & Co. KGaA


• Neurosoft


• Integra LifeSciences Corporation


• Olympus Corporation

Frequently Asked Questions (FAQ) :